Hospital-Acquired Infections Hit 15.7 Percent Globally as Drug-Resistant Superbugs Spread

Hospitals are supposed to be places of healing, but a sweeping new analysis of global evidence confirms that they remain one of the most dangerous environments a vulnerable patient can occupy. A systematic review published in BMC Infectious Diseases has pulled together decades of data on hospital-acquired infections, the pathogens behind them, and the alarming antimicrobial resistance patterns that complicate their treatment. The findings paint a sobering picture: across the studies included in the review, the overall observed prevalence of hospital-acquired infections reached 15.72 percent, with the burden falling heaviest on low- and middle-income regions where infection prevention infrastructure is often stretched thin.

The research team, led by Fatemeh Sameni and Masoud Dadashi with colleagues at institutions including Shahid Beheshti University of Medical Sciences and Alborz University of Medical Sciences in Iran, conducted a systematic literature search across three major databases: Medline via PubMed, Embase, and Web of Science. They targeted studies published between January 2000 and December 2025, casting a wide net over a quarter century of clinical research. To be included, studies had to report the prevalence of hospital-acquired infections in human populations and provide sufficient demographic and microbiological data. Two independent reviewers screened titles, abstracts, and full texts, extracted the relevant data, and assessed study quality using the Joanna Briggs Institute checklist, a standardized tool for appraising the methodological rigor of prevalence studies.

One of the most statistically important findings concerns the limits of the analysis itself. The overall observed prevalence of 15.72 percent could not be formally pooled into a single meta-analytic estimate because the underlying studies were extraordinarily heterogeneous, with an I² statistic of 99 percent. In practical terms, this means the variation between studies was almost entirely due to real differences in settings, methods, and populations rather than random chance, so averaging them into one number would be misleading. The authors were transparent about this constraint, presenting the observed prevalence while cautioning readers against overinterpreting it as a universal figure. This kind of statistical honesty is increasingly valued in evidence synthesis, where the temptation to produce a single headline number often obscures the messier truth.

What the data do show clearly is a stark geographic gradient. The highest prevalence figures were reported in Asia, at 43.04 percent, and Africa, at 34.07 percent, while India exhibited the highest national prevalence at 24.28 percent. These figures reflect the conditions under which the contributing studies were conducted, including the types of hospitals, the patient populations, and the surveillance methods used, but they align with a well-documented pattern: healthcare systems with fewer resources for hand hygiene, sterile equipment, isolation facilities, and laboratory diagnostics tend to report higher rates of infections acquired within their walls. In intensive care units, where patients are immunocompromised, invasively monitored, and exposed to multiple devices, the risks multiply.

The microbiological cast of characters behind these infections is dominated by a familiar lineup of opportunistic pathogens. The most frequently identified organisms were Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. Each of these species has earned a fearsome reputation in clinical microbiology. S. aureus colonizes skin and nasal passages and is a leading cause of surgical site and bloodstream infections. E. coli drives catheter-associated urinary tract infections. P. aeruginosa thrives in moist hospital environments and attacks ventilated patients. K. pneumoniae and A. baumannii have become notorious for their capacity to acquire resistance genes and spread within hospital wards, with A. baumannii in particular emerging as a poster pathogen for the antimicrobial resistance crisis in conflict zones and intensive care settings.

The resistance data are where the review becomes genuinely alarming. Among 300 S. aureus isolates assessed for vancomycin susceptibility, 35 isolates, or 11.66 percent, were reported as vancomycin-resistant S. aureus, or VRSA. Vancomycin has long been the last-line treatment for serious methicillin-resistant S. aureus infections, so the emergence of strains that defeat it represents a clinical worst case. The authors are careful to note that this proportion reflects only the isolates evaluated in the contributing studies and should not be interpreted as the global prevalence of VRSA, a caveat that matters because the isolates tested were likely enriched for problematic strains. Even so, the finding underscores how far resistance to last-resort antibiotics has penetrated hospital ecosystems.

Beyond the staphylococci, the review catalogued the broader vocabulary of multidrug resistance that now defines hospital infectious diseases: methicillin-resistant S. aureus, vancomycin-resistant enterococci, carbapenem-resistant Enterobacteriaceae, and extended-spectrum beta-lactamase producing Gram-negative bacilli. Multidrug-resistant organisms complicate patient management worldwide because each resistant infection demands longer hospitalization, more toxic and expensive second-line drugs, and often leaves clinicians with few or no effective options. The authors also acknowledged a significant data gap: due to insufficient and inconsistent reporting across the included studies, resistance to colistin, itself a last-resort antibiotic for carbapenem-resistant Gram-negative infections, could not be comprehensively evaluated. That blind spot is itself a warning about the state of global surveillance.

In terms of infection types, respiratory tract infections, urinary tract infections, and surgical site infections emerged as the most common categories of hospital-acquired infection, particularly among patients admitted to intensive care units. This distribution maps directly onto modern critical care practice. Mechanical ventilation bypasses the natural defenses of the airway, urinary catheters provide a highway for bacteria into the bladder, and surgery creates wounds that pathogens can colonize. The review’s terminology reflects the standard epidemiological categories: central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and surgical site infections, each with its own prevention bundle of evidence-based interventions such as hand hygiene, chlorhexidine bathing, subglottic suctioning, and early device removal.

The methodological machinery behind the review is worth appreciating. The authors followed PRISMA, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, the international standard for transparent evidence synthesis. Pathogen identification across the included studies relied on techniques ranging from conventional culture and biochemical testing to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, a rapid proteomic method that has revolutionized clinical microbiology, while susceptibility testing followed standards set by the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility Testing. The heterogeneity that prevented meta-analysis is a common feature of prevalence reviews spanning diverse countries and decades, but it also highlights the need for standardized surveillance definitions so that data from different settings can be meaningfully compared.

The conclusions the authors draw are directed squarely at policymakers and hospital leaders. Strengthening infection prevention and control measures, expanding antimicrobial stewardship programs, and building robust global surveillance systems are described as essential to reducing the burden of hospital-acquired infections and improving patient outcomes. Antimicrobial stewardship, the coordinated effort to prescribe antibiotics only when needed and at the right dose and duration, preserves the effectiveness of existing drugs while new ones are developed. Surveillance, meanwhile, is the foundation of any response: without knowing which pathogens are circulating and which drugs still work, clinicians are prescribing blind. As multidrug-resistant organisms continue to spread, the review serves as both a comprehensive baseline and a call to action, reminding the global health community that the fight against hospital infections is won or lost at the bedside, one hand wash, one catheter, and one prescription at a time.

Subject of Research: Global prevalence, microbial etiology, and antimicrobial resistance patterns of hospital-acquired infections

Article Title: Global prevalence, pathogens, and antimicrobial resistance patterns in hospital-acquired infections: a systematic review

Article References: Global prevalence, pathogens, and antimicrobial resistance patterns in hospital-acquired infections: a systematic review. (n.d.). https://doi.org/10.1186/s12879-026-14614-7

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14614-7

Keywords: hospital-acquired infections, nosocomial infection, antimicrobial resistance, multidrug resistance, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii, intensive care unit, systematic review, infection prevention and control